logo
  

Fortive Raises FY21 Earnings Outlook

Fortive Corp. (FTV) Thursday raised its earnings and revenue guidance for the full year 2021.

For the full year 2021, Fortive now anticipates earnings from continuing operations to be in the range of $1.70 to $1.80 per share and adjusted earnings from continuing operations to be in the range of $2.65 to $2.75 per share.

Previously, for the full year 2021, Fortive expected net earnings from continuing operations to be in the range of $1.50 to $1.60 per share and adjusted diluted net earnings from continuing operations to be in the range of $2.50 to $2.60 per share.

For the third quarter, Fortive anticipates net earnings from continuing operations to be in the range of $0.41 to $0.45 per share and adjusted net earnings from continuing operations to be in the range of $0.62 to $0.66 per share.

Analysts polled by Thomson Reuters currently estimate earnings of $0.63 per share and $2.60 per share for the full year 2021.

CEO James Lico said, "We are excited about our recently announced acquisition of ServiceChannel. The transaction adds another differentiated, high-growth SaaS asset with an attractive runway to drive increasing profitability and free cash flow, and generate strong returns over the next five years. As we look ahead, we have significant capacity and opportunity for additional capital allocation which will continue to strengthen the portfolio and drive double-digit earnings and free cash flow growth over the long-term."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates. Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals.
Follow RTT